121 related articles for article (PubMed ID: 9315571)
1. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction.
Cannon CP; Sharis PJ; Schweiger MJ; McCabe CH; Diver DJ; Shah PK; Sequeira RF; Greene RM; Perritt RL; Poole WK; Braunwald E
Am J Cardiol; 1997 Sep; 80(6):696-9. PubMed ID: 9315571
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
[TBL] [Abstract][Full Text] [Related]
3. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.
Gibson CM; Murphy SA; Rizzo MJ; Ryan KA; Marble SJ; McCabe CH; Cannon CP; Van de Werf F; Braunwald E
Circulation; 1999 Apr; 99(15):1945-50. PubMed ID: 10208996
[TBL] [Abstract][Full Text] [Related]
4. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
[TBL] [Abstract][Full Text] [Related]
5. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
[TBL] [Abstract][Full Text] [Related]
6. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Antman EM
Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
Truong QA; Cannon CP; Zakai NA; Rogers IS; Giugliano RP; Wiviott SD; McCabe CH; Morrow DA; Braunwald E
Am Heart J; 2009 Apr; 157(4):673-9.e1. PubMed ID: 19332194
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.
Shimpo M; Morrow DA; Weinberg EO; Sabatine MS; Murphy SA; Antman EM; Lee RT
Circulation; 2004 May; 109(18):2186-90. PubMed ID: 15117853
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
12. [Primary coronary angioplasty for acute myocardial infarction associated with severe left ventricular dysfunction. Results in 50 patients].
Antoniucci D; Santoro GM; Bolognese L; Valenti R; Leoncini M; Fazzini PF
G Ital Cardiol; 1995 Oct; 25(10):1265-71. PubMed ID: 8682222
[TBL] [Abstract][Full Text] [Related]
13. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
[TBL] [Abstract][Full Text] [Related]
14. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
15. [Predict value of clinical risk score, thrombolysis in myocardial infarction flow grade and combined clinical risk score plus TIMI flow on outcome evaluation of patients with acute coronary syndrome].
Zhong B; Liu ZZ; Su L; Lan XB; Chen YQ; Ling ZY; Yin YH
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):30-5. PubMed ID: 19099923
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.
O'Connor CM; Hathaway WR; Bates ER; Leimberger JD; Sigmon KN; Kereiakes DJ; George BS; Samaha JK; Abbottsmith CW; Candela RJ; Topol EJ; Califf RM
Am Heart J; 1997 Jun; 133(6):663-73. PubMed ID: 9200394
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
[TBL] [Abstract][Full Text] [Related]
19. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
Ke D; Zhong W; Fan L; Chen L
Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
[TBL] [Abstract][Full Text] [Related]
20. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
